Real-world experience with targeted therapy in patients with histiocytic neoplasms in the Netherlands and in Belgium
PG Kemps, FJSH Woei-A-Jin, P Schöffski, T Tousseyn… - Blood Neoplasia, 2024 - Elsevier
Histiocytic disorders are rare hematologic neoplasms characterized by a notable
dependence on mitogen-activated protein kinase signaling. With conventional therapies, a …
dependence on mitogen-activated protein kinase signaling. With conventional therapies, a …